Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 836564, 10 pages
http://dx.doi.org/10.1155/2015/836564
Research Article

Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells

1Cell-Based Drug and Health Product Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
2Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

Received 29 March 2015; Revised 16 July 2015; Accepted 21 July 2015

Academic Editor: Shrikant Anant

Copyright © 2015 Narumol Bhummaphan and Pithi Chanvorachote. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Bao, A. Ahmad, A. S. Azmi, S. Ali, and F. H. Sarkar, “Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy,” in Current Protocols in Pharmacology, S. J. Enna, Ed., Unit 14.25, pp. 1–14, John Wiley & Sons, 2013. View at Publisher · View at Google Scholar
  2. F. Li, B. Tiede, J. Massagué, and Y. Kang, “Beyond tumorigenesis: cancer stem cells in metastasis,” Cell Research, vol. 17, no. 1, pp. 3–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Cheng, A. V. Ramesh, A. Flesken-Nikitin, J. Choi, and A. Y. Nikitin, “Mouse models for cancer stem cell research,” Toxicologic Pathology, vol. 38, no. 1, pp. 62–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Vinogradov and X. Wei, “Cancer stem cells and drug resistance: the potential of nanomedicine,” Nanomedicine, vol. 7, no. 4, pp. 597–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. A. Lobo, Y. Shimono, D. Qian, and M. F. Clarke, “The biology of cancer stem cells,” Annual Review of Cell and Developmental Biology, vol. 23, pp. 675–699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Yongsanguanchai, V. Pongrakhananon, A. Mutirangura, Y. Rojanasakul, and P. Chanvorachote, “Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells,” The American Journal of Physiology—Cell Physiology, vol. 308, no. 2, pp. C89–C100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-H. Chiou, M.-L. Wang, Y.-T. Chou et al., “Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation,” Cancer Research, vol. 70, no. 24, pp. 10433–10444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K.-H. Wang, A.-P. Kao, C.-C. Chang, T.-C. Lin, and T.-C. Kuo, “Upregulation of Nanog and Sox-2 genes following ectopic expression of Oct-4 in amniotic fluid mesenchymal stem cells,” Biotechnology and Applied Biochemistry, 2015. View at Publisher · View at Google Scholar
  9. T. Nagata, Y. Shimada, S. Sekine et al., “Prognostic significance of NANOG and KLF4 for breast cancer,” Breast Cancer, vol. 21, no. 1, pp. 96–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Shan, J. Shen, L. Liu et al., “Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma,” Hepatology, vol. 56, no. 3, pp. 1004–1014, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Kumar, S. Liu, H. Lu et al., “Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation,” Oncogene, vol. 31, no. 47, pp. 4898–4911, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Samardzija, M. Quinn, J. K. Findlay, and N. Ahmed, “Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary,” Journal of Ovarian Research, vol. 5, pp. 1757–2215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Atlasi, S. J. Mowla, S. A. M. Ziaee, and A.-R. Bahrami, “OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer,” International Journal of Cancer, vol. 120, no. 7, pp. 1598–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Zhang, L. A. Espinoza, R. J. Kinders et al., “NANOG modulates stemness in human colorectal cancer,” Oncogene, vol. 32, no. 37, pp. 4397–4405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-C. Tsai, P.-F. Su, Y.-F. Huang, T.-L. Yew, and S.-C. Hung, “Oct4 and nanog directly regulate dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells,” Molecular Cell, vol. 47, no. 2, pp. 169–182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Liu, X. Yu, and S. Liu, “Pluripotency transcription factors and cancer stem cells: small genes make a big difference,” Chinese Journal of Cancer, vol. 32, no. 9, pp. 483–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. H. Noh, B. W. Kim, K.-H. Song et al., “Nanog signaling in cancer promotes stem-like phenotype and immune evasion,” The Journal of Clinical Investigation, vol. 122, no. 11, pp. 4077–4093, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. G. Jiang, H. Y. Lu, G. Zhang, L. X. Zhang, and X. Y. Gao, “Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self-renewal of lung cancer stem cells,” Molecular Medicine Reports, vol. 12, no. 1, pp. 363–370, 2015. View at Publisher · View at Google Scholar
  19. W. S. Kim, Y. Zhu, Q. Deng et al., “Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling,” Stem Cells, vol. 32, no. 6, pp. 1503–1514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Lin, Z. Yang, A. Xu et al., “PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway,” Scientific Reports, vol. 5, article 8997, 2015. View at Publisher · View at Google Scholar
  21. A. Dubrovska, S. Kim, R. J. Salamone et al., “The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 268–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Gargini, J. P. Cerliani, M. Escoll, I. M. Antõn, and F. Wandosell, “Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/bim pathway,” Stem Cells, vol. 33, no. 3, pp. 646–660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Kumar, S. Shankar, and R. K. Srivastava, “Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms,” Molecular Cancer, vol. 12, no. 1, article 171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Lin, Y. Yang, W. Li et al., “Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells,” Molecular Cell, vol. 48, no. 4, pp. 627–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-L. Wang, S.-H. Chiou, and C.-W. Wu, “Targeting cancer stem cells: emerging role of Nanog transcription factor,” OncoTargets and Therapy, vol. 6, pp. 1207–1220, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Q.-W. Zhao, Y.-W. Zhou, W.-X. Li et al., “Akt-mediated phosphorylation of Oct4 is associated with the proliferation of stem-like cancer cells,” Oncology Reports, vol. 33, no. 4, pp. 1621–1629, 2015. View at Publisher · View at Google Scholar
  27. S. Charoenrungruang, P. Chanvorachote, B. Sritularak, and V. Pongrakhananon, “Gigantol, a bibenzyl from Dendrobium draconis, inhibits the migratory behavior of non-small cell lung cancer cells,” Journal of Natural Products, vol. 77, no. 6, pp. 1359–1366, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Sritularak, M. Anuwat, and K. Likhitwitayawuid, “A new phenanthrenequinone from Dendrobium draconis,” Journal of Asian Natural Products Research, vol. 13, no. 3, pp. 251–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Fotakis and J. A. Timbrell, “In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride,” Toxicology Letters, vol. 160, no. 2, pp. 171–177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Foglieni, C. Meoni, and A. M. Davalli, “Fluorescent dyes for cell viability: an application on prefixed conditions,” Histochemistry and Cell Biology, vol. 115, no. 3, pp. 223–229, 2001. View at Google Scholar · View at Scopus
  31. C. Kantara, M. O'Connell, S. Sarkar, S. Moya, R. Ullrich, and P. Singh, “Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA,” Cancer Research, vol. 74, no. 9, pp. 2487–2498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Martelli, C. Evangelisti, M. Y. Follo et al., “Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells,” Current Medicinal Chemistry, vol. 18, no. 18, pp. 2715–2726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Hambardzumyan, O. J. Becher, M. K. Rosenblum, P. P. Pandolfi, K. Manova-Todorova, and E. C. Holland, “PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo,” Genes and Development, vol. 22, no. 4, pp. 436–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. K. C. Davidson, A. M. Adams, J. M. Goodson et al., “Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 12, pp. 4485–4490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Xenopoulos, M. Kang, A. Puliafito, S. Di Talia, and A. K. Hadjantonakis, “Heterogeneities in nanog expression drive stable commitment to pluripotency in the mouse blastocyst,” Cell Reports, vol. 10, no. 9, pp. 1508–1520, 2015. View at Publisher · View at Google Scholar
  36. S. Mora-Castilla, J. R. Tejedo, A. Hmadcha et al., “Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation,” Cell Death and Differentiation, vol. 17, no. 6, pp. 1025–1033, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. E. M. Abdelalim and I. Tooyama, “NPR-A regulates self-renewal and pluripotency of embryonic stem cells,” Cell Death and Disease, vol. 2, no. 3, article e127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Korkaya, A. Paulson, E. Charafe-Jauffret et al., “Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling,” PLoS Biology, vol. 7, no. 6, Article ID e1000121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Tada, H. Fukuda, K. Nakagawa et al., “Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection,” International Journal of Clinical Oncology, vol. 10, no. 6, pp. 425–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. P. Sullivan, J. D. Minna, and J. W. Shay, “Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy,” Cancer and Metastasis Reviews, vol. 29, no. 1, pp. 61–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Lawlor and D. R. Alessi, “PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?” Journal of Cell Science, vol. 114, no. 16, pp. 2903–2910, 2001. View at Google Scholar · View at Scopus
  42. J. Qin, J. Ji, R. Deng et al., “DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2,” Oncotarget, vol. 4, 4 pages, 2015. View at Google Scholar
  43. Y. Wu and P. Y. Wu, “CD133 as a marker for cancer stem cells: progresses and concerns,” Stem Cells and Development, vol. 18, no. 8, pp. 1127–1134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Mizugaki, J. Sakakibara-Konishi, J. Kikuchi et al., “CD133 expression: a potential prognostic marker for non-small cell lung cancers,” International Journal of Clinical Oncology, vol. 19, no. 2, pp. 254–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Okudela, T. Woo, H. Mitsui et al., “Downregulation of ALDH1A1 expression in non-small cell lung carcinomas—its clinicopathologic and biological significance,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 1, pp. 1–12, 2013. View at Google Scholar · View at Scopus
  46. M. Patel, L. Lu, D. S. Zander, L. Sreerama, D. Coco, and J. S. Moreb, “ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors,” Lung Cancer, vol. 59, no. 3, pp. 340–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Zhang, Y. Lou, H. Wang et al., “Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells,” Medical Oncology, vol. 32, no. 4, 2015. View at Publisher · View at Google Scholar
  48. C. R. Jeter, B. Liu, X. Liu et al., “NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation,” Oncogene, vol. 30, no. 36, pp. 3833–3845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Zhu, F. Yin, L. Yang et al., “Contribution of TIP30 to chemoresistance in laryngeal carcinoma,” Cell Death and Disease, vol. 5, no. 10, article e1468, 2014. View at Publisher · View at Google Scholar
  50. C.-E. Huang, F.-W. Hu, C.-H. Yu et al., “Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells,” International Journal of Molecular Sciences, vol. 15, no. 10, pp. 18623–18639, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. E. M. Abdelalim and I. Tooyama, “Knockdown of p53 suppresses Nanog expression in embryonic stem cells,” Biochemical and Biophysical Research Communications, vol. 443, no. 2, pp. 652–657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-D. Wang, N. Cai, X.-L. Wu, H.-Z. Cao, L.-L. Xie, and P.-S. Zheng, “OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway,” Cell Death and Disease, vol. 4, no. 8, article e760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Matsubara, Q. Ding, Y. Miyazaki, T. Kuwahata, K. Tsukasa, and S. Takao, “MTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions,” Scientific Reports, vol. 3, article 3230, 2013. View at Publisher · View at Google Scholar · View at Scopus